Examining Pharmacoequity in Older Inflammatory Bowel Disease Patients.
作者信息
Lichtenstein Gary R
出版信息
Gastroenterol Hepatol (N Y). 2024 Aug;20(8):435.
Abstract
摘要
相似文献
1
Examining Pharmacoequity in Older Inflammatory Bowel Disease Patients.
Gastroenterol Hepatol (N Y). 2024 Aug;20(8):435.
2
Pharmacoequity in Older Patients With Inflammatory Bowel Disease.
Gastroenterol Hepatol (N Y). 2024 Aug;20(8):494-503.
3
Pharmacoequity for Older Adults With Inflammatory Bowel Diseases.
Clin Gastroenterol Hepatol. 2024 Feb;22(2):209-214. doi: 10.1016/j.cgh.2023.11.012.
4
Pharmacoequity for Older Adults With Inflammatory Bowel Diseases.
Gastroenterology. 2024 Feb;166(2):235-239. doi: 10.1053/j.gastro.2023.12.005.
5
Pharmacoequity and Biologics in the Allergy Clinic: Providing the Right Care, at the Right Time, Every Time, to Everyone.
J Allergy Clin Immunol Pract. 2024 May;12(5):1170-1180. doi: 10.1016/j.jaip.2024.02.039. Epub 2024 Mar 6.
6
Pursuing Pharmacoequity: Determinants, Drivers, and Pathways to Progress.
J Health Polit Policy Law. 2022 Dec 1;47(6):709-729. doi: 10.1215/03616878-10041135.
7
Pharmacoequity in Allergy-Immunology: Disparities in Access to Medications for Allergic Diseases and Proposed Solutions in the United States and Globally.
J Allergy Clin Immunol Pract. 2024 Feb;12(2):272-280. doi: 10.1016/j.jaip.2023.11.005. Epub 2023 Nov 10.
8
Eliminating Health Disparities in Atrial Fibrillation, Heart Failure, and Dyslipidemia: A Path Toward Achieving Pharmacoequity.
Curr Atheroscler Rep. 2023 Dec;25(12):1113-1127. doi: 10.1007/s11883-023-01180-5. Epub 2023 Dec 18.
9
Older people and inflammatory bowel disease: a systematic review.
J Clin Nurs. 2008 Nov;17(11c):400-6. doi: 10.1111/j.1365-2702.2008.02577.x.
10
The Experiences of Older Adults Living With Inflammatory Bowel Disease: A Scoping Review.
Gastroenterol Nurs. 2023;46(4):296-308. doi: 10.1097/SGA.0000000000000737. Epub 2023 May 9.
Zotero 插件